161 related articles for article (PubMed ID: 25594014)
1. Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor.
McCann GA; Naidu S; Rath KS; Bid HK; Tierney BJ; Suarez A; Varadharaj S; Zhang J; Hideg K; Houghton P; Kuppusamy P; Cohn DE; Selvendiran K
Oncoscience; 2014; 1(3):216-28. PubMed ID: 25594014
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3.
Selvendiran K; Bratasz A; Kuppusamy ML; Tazi MF; Rivera BK; Kuppusamy P
Int J Cancer; 2009 Nov; 125(9):2198-204. PubMed ID: 19623660
[TBL] [Abstract][Full Text] [Related]
3. Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinoma.
Bixel K; Saini U; Kumar Bid H; Fowler J; Riley M; Wanner R; Deepa Priya Dorayappan K; Rajendran S; Konishi I; Matsumura N; Cohn DE; Selvendiran K
Int J Cancer; 2017 Nov; 141(9):1856-1866. PubMed ID: 28646535
[TBL] [Abstract][Full Text] [Related]
4. Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor.
Tierney BJ; McCann GA; Naidu S; Rath KS; Saini U; Wanner R; Kuppusamy P; Suarez A; Goodfellow PJ; Cohn DE; Selvendiran K
Gynecol Oncol; 2014 Oct; 135(1):133-41. PubMed ID: 25038288
[TBL] [Abstract][Full Text] [Related]
5. Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target.
Saini U; Naidu S; ElNaggar AC; Bid HK; Wallbillich JJ; Bixel K; Bolyard C; Suarez AA; Kaur B; Kuppusamy P; Hays J; Goodfellow PJ; Cohn DE; Selvendiran K
Oncogene; 2017 Jan; 36(2):168-181. PubMed ID: 27292260
[TBL] [Abstract][Full Text] [Related]
6.
Saini U; Suarez AA; Naidu S; Wallbillich JJ; Bixel K; Wanner RA; Bice J; Kladney RD; Lester J; Karlan BY; Goodfellow PJ; Cohn DE; Selvendiran K
Cancer Res; 2018 Apr; 78(7):1739-1750. PubMed ID: 29339537
[TBL] [Abstract][Full Text] [Related]
7. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J
Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503
[TBL] [Abstract][Full Text] [Related]
8. Nuclear expression of pSTAT3
Marginean FE; Hellsten R; Krzyzanowska A; Bjartell A
Pathol Res Pract; 2022 Apr; 232():153811. PubMed ID: 35259550
[TBL] [Abstract][Full Text] [Related]
9. Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and H-4318, in cisplatin resistant primary ovarian cancer.
ElNaggar AC; Saini U; Naidu S; Wanner R; Sudhakar M; Fowler J; Nagane M; Kuppusamy P; Cohn DE; Selvendiran K
Cancer Biol Ther; 2016 Oct; 17(10):1107-1115. PubMed ID: 27415751
[TBL] [Abstract][Full Text] [Related]
10. Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells.
Shin DS; Kim HN; Shin KD; Yoon YJ; Kim SJ; Han DC; Kwon BM
Cancer Res; 2009 Jan; 69(1):193-202. PubMed ID: 19118003
[TBL] [Abstract][Full Text] [Related]
11. [Effects of siltuximab on the interleukin-6/Stat3 signaling pathway in ovarian cancer].
Guo YQ; Lu P; Duan ZF; Zhang Z
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):854-9. PubMed ID: 21211286
[TBL] [Abstract][Full Text] [Related]
12. The Antiproliferative and Colony-suppressive Activities of STAT3 Inhibitors in Human Cancer Cells Is Compromised Under Hypoxic Conditions.
Tian J; Xiao H; Wu R; Cao Y; Li C; Xu R; Pierson CR; Finlay JL; Yang F; Gu N; Lin J
Anticancer Res; 2017 Feb; 37(2):547-553. PubMed ID: 28179300
[TBL] [Abstract][Full Text] [Related]
13. Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells.
Han Z; Feng J; Hong Z; Chen L; Li W; Liao S; Wang X; Ji T; Wang S; Ma D; Chen G; Gao Q
Biochem Biophys Res Commun; 2013 May; 435(2):188-94. PubMed ID: 23665025
[TBL] [Abstract][Full Text] [Related]
14. HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling.
Xue X; Jungles K; Onder G; Samhoun J; Győrffy B; Hardiman KM
Oncotarget; 2016 Mar; 7(10):11567-79. PubMed ID: 26871465
[TBL] [Abstract][Full Text] [Related]
15. In vivo evidence suggesting reciprocal renal hypoxia-inducible factor-1 upregulation and signal transducer and activator of transcription 3 activation in response to hypoxic and non-hypoxic stimuli.
Nechemia-Arbely Y; Khamaisi M; Rosenberger C; Koesters R; Shina A; Geva C; Shriki A; Klaus S; Rosen S; Rose-John S; Galun E; Axelrod JH; Heyman SN
Clin Exp Pharmacol Physiol; 2013 Apr; 40(4):262-72. PubMed ID: 23384058
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer.
Jia ZH; Jia Y; Guo FJ; Chen J; Zhang XW; Cui MH
PLoS One; 2017; 12(8):e0183622. PubMed ID: 28859117
[TBL] [Abstract][Full Text] [Related]
17. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV
Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221
[TBL] [Abstract][Full Text] [Related]
18. The protective microRNA-199a-5p-mediated unfolded protein response in hypoxic cardiomyocytes is regulated by STAT3 pathway.
Zhou Y; Pang B; Xiao Y; Zhou S; He B; Zhang F; Liu W; Peng H; Li P
J Physiol Biochem; 2019 Feb; 75(1):73-81. PubMed ID: 30426460
[TBL] [Abstract][Full Text] [Related]
19. A perylene derivative regulates HIF-1α and Stat3 signaling pathways.
Chen H; Guan Y; Yuan G; Zhang Q; Jing N
Bioorg Med Chem; 2014 Feb; 22(4):1496-505. PubMed ID: 24485121
[TBL] [Abstract][Full Text] [Related]
20. STAT3 Regulation By S-Nitrosylation: Implication In Cancer.
Singh I; Kim J; Singh AK; Sharma AK; Won JS
Redox Biol; 2015 Aug; 5():416-417. PubMed ID: 28162277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
